Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature*

By P. Marik, H. Corwin. Critical Care Medicine, 2008

916 citations recorded by the source corpus.

Subfields: Biochemistry, Critical Care and Intensive Care Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/2d294910cecff4ed9fb9cdb3d3b03eacc2ceec65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biochemistry

1. P. Marik

In Critical Care and Intensive Care Medicine

1. M. Flemmer
2. Jean-Louis Vincent
3. P. Marik

In Epidemiology

1. M. Flemmer
2. Jean-Louis Vincent
3. P. Marik
4. Leo Anthony Celi
5. Marzyeh Ghassemi

Citations in the corpus

• Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB* (2012, background): “The panel recognized that observational studies in patients with the acute coronary syndrome have been reported (58) but, because of uncontrolled confounding, believed that the evidence from these types of studies was insufficient to support clear recommendations.”
• The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition (2019, background): “Nevertheless, RBC transfusions have been shown in multiple studies to be associated with increased mortality [390–394], lung injury [391, 395, 396], increased infection rates [397, 398] and renal failure in trauma victims [394].”
• Management of bleeding and coagulopathy following major trauma: an updated European guideline (2013, background): “increased infection rates [220,221] and renal failure in”
• Management of bleeding following major trauma: an updated European guideline (2010, neutral): “shown in multiple studies to be associated with increased mortality [230-234], lung injury [234-236], increased infection rates [237,238] and renal failure in trauma victims [233].”
• Narrative Review (2012, background): “Blood transfusion (a single unit at a time) should only be considered in highly symptomatic patients with hemoglobin below 7 to 8 g/dL.(104) Intravenous iron (200 mg ferric carboxymaltose) has been demonstrated to improve symptoms in NYHA class II or III patients who had an EF of less than 45% and h”
• The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition (2016, background): “Nevertheless, RBC transfusions have been shown in 28 multiple studies to be associated with increased mortality [266-270], lung injury [270-272], 29 increased infection rates [273, 274] and renal failure in trauma victims [269].”